KESIMPTA PEN (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSING FORM OF MULTIPLE SCLEROSIS ·+1
Novartis Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
RITUXAN (rituximab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA ·+10
GENENTECH
ADCETRIS (brentuximab vedotin)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · HODGKIN'S LYMPHOMA ·+4
SEATTLE GENETIC
GAZYVA (obinutuzumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · CHRONIC LYMPHOCYTIC LEUKEMIA ·+4
GENENTECH
LEMTRADA (alemtuzumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSING FORM OF MULTIPLE SCLEROSIS ·+1
GENZYME
ARZERRA (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · CHRONIC LYMPHOCYTIC LEUKEMIA ·+2
Novartis Pharmaceuticals
RITUXAN HYCELA (rituximab/hyaluronidase, human recombinant)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · CHRONIC LYMPHOCYTIC LEUKEMIA ·+2
GENENTECH
MYLOTARG (gemtuzumab ozogamicin)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · CD33 POSITIVE ACUTE MYELOID LEUKEMIA
Wyeth Pharmaceutical
POTELIGEO (mogamulizumab-kpkc)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · MYCOSIS FUNGOIDES ·+1
KYOWA KIRIN, IN
POLIVY (polatuzumab vedotin-piiq)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · DIFFUSE LARGE B-CELL LYMPHOMA
GENENTECH
TRUXIMA (rituximab-abbs)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA ·+7
CEPHALON,INC.
PADCEV (enfortumab vedotin-ejfv)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · INVASIVE BLADDER CANCER ·+1
SEATTLE GENETIC
RUXIENCE (rituximab-pvvr)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA ·+7
Parke-Davis Pfizer
BLENREP (belantamab mafodotin-blmf)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · MULTIPLE MYELOMA
GSK
KESIMPTA PEN (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSING FORM OF MULTIPLE SCLEROSIS ·+1
Novartis Pharmaceuticals
RIABNI (rituximab-arrx)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA ·+9
AMGEN
ZYNLONTA (loncastuximab tesirine-lpyl)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · PROGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA
ADC THERAPEUTIC
ELAHERE (mirvetuximab soravtansine-gynx)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · FOLATE RECEPTOR ALPHA POSITIVE EPITHELIAL OVARIAN CANCER
IMMUNOGEN, INC.
UPLIZNA (inebilizumab-cdon)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · NEUROMYELITIS OPTICA SPECTRUM DISORDER WITH ANTI-AQUAPORIN-4 (AQP4) ANTIBODIES ·+3
HORIZON/AMGEN
MONJUVI (tafasitamab-cxix)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · FOLLICULAR LYMPHOMA ·+1
MORPHOSYS/INCYT
ELAHERE (mirvetuximab soravtansine-gynx)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · FOLATE RECEPTOR ALPHA POSITIVE EPITHELIAL OVARIAN CANCER
ABBOTT
MONJUVI (tafasitamab-cxix)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · FOLLICULAR LYMPHOMA ·+1
Incyte Corporation
ZIIHERA (zanidatamab-hrii)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · HER2-POSITIVE ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION ·+3
JAZZ PHARMACEUT
BIZENGRI (zenocutuzumab-zbco)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · NEUREGULIN 1 GENE FUSION POSITIVE PANCREATIC ADENOCARCINOMA ·+2
SANOFI/PARTNER
VYLOY (zolbetuximab-clzb)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · HER2-NEG AND CLDN 18.2 POS GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Astellas Pharma US